Med-Chemist : "Quintessential Medicinal Chemistry"
Saturday, January 9, 2021
Early treatment with lorlatinib improves survival in some lung cancer patients: Lung cancer patients with a specific genetic alteration lived longer and were protected against metastasis to the brain when treated early with lorlatinib
›
In continuation of my update on Lorlatinib Non-small-cell lung cancer (NSCLC) accounts for 87% of all cases of lung cancer. Some 5% of NSCLC...
Friday, January 8, 2021
FDA Approves Xaracoll (bupivacaine hydrochloride) Implant for Acute Postsurgical Pain Relief Following Open Inguinal Hernia Repair
›
In continuation of my update on bupivacaine Innocoll Holdings Limited, a specialty pharmaceutical company and portfolio business of Gurnet ...
Thursday, January 7, 2021
FDA Approves Winlevi (clascoterone) Cream for the Treatment of Acne
›
Cassiopea SpA (SIX: SKIN), announced the United States Food and Drug Administration (FDA) approval of Winlevi (clascoterone cream 1%) fo...
Saturday, January 2, 2021
Cow's Milk Intake While Breastfeeding May Cut Child Food Allergies
›
In continuation of my update on cow milk Children whose mothers drink more cow's milk during breastfeeding are at a lower risk for deve...
Friday, January 1, 2021
AHA: Mavacamten May Treat Hypertrophic Cardiomyopathy
›
Compared with placebo, mavacamten (Mava), a novel inhibitor of cardiac myosin, for 30 weeks leads to improvement in left ventricular (LV) hy...
Thursday, December 31, 2020
FDA Approves Viltepso (viltolarsen) for the Treatment of Duchenne Muscular Dystrophy in Patients Amenable to Exon 53 Skipping Therapy
›
NS Pharma, Inc. announced the U.S. Food & Drug Administration (FDA) has approved Viltepso (viltolarsen) injection for patients with Duc...
Wednesday, December 30, 2020
FDA Approves Evrysdi (risdiplam) for Treatment of Spinal Muscular Atrophy (SMA) in Adults and Children 2 Months and Older
›
Genentech, a member of the Roche Group, announced the U.S. Food and Drug Administration (FDA) approval of Evrysdi (risdiplam) for treatment ...
Tuesday, December 15, 2020
FDA Approves Lampit (nifurtimox) for the Treatment of Chagas Disease in Children
›
Bayer announced that the United States Food and Drug Administration (FDA) has approved Lampit (nifurtimox) for use in pediatric patients (...
Monday, December 14, 2020
Fluvoxamine may prevent serious illness in COVID-19 patients, study suggests: Antidepressant drug repurposed for patients with coronavirus infection
›
In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Wash...
Thursday, November 19, 2020
FDA Approves Zeposia (ozanimod) for Relapsing Forms of Multiple Sclerosis
›
Myers Squibb Company (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) approved Zeposia (ozanimod) 0.92 mg for the t...
Tuesday, November 17, 2020
Kratom Seems Safe for Pain, Anxiety, Opioid Withdrawal
›
We know that, Mitragyna speciosa (commonly known as kratom is a tropical evergreen tree in the coffee family native to Southeast As...
Friday, November 13, 2020
FDA Approves Isturisa (osilodrostat) for the Treatment of Cushing’s Disease
›
The U.S. Food and Drug Administration today approved Isturisa (osilodrostat) oral tablets for adults with Cushing’s disease who either can...
FDA Approves Durysta (bimatoprost implant) to Lower Intraocular Pressure In Open-Angle Glaucoma or Ocular Hypertension Patients
›
Allergan plc (NYSE: AGN), a leading global pharmaceutical company with more than 70 years of heritage in eye care, announced the U.S. Food a...
‹
›
Home
View web version